Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Future Pandemic Influenza Virus Detection Relies on the Existing Influenza Surveillance Systems: A Perspective from Australia and New Zealand.

Jennings LC, Barr IG.

Trop Med Infect Dis. 2019 Sep 23;4(4). pii: E121. doi: 10.3390/tropicalmed4040121.

2.

Intense interseasonal influenza outbreaks, Australia, 2018/19.

Barr IG, Deng YM, Grau ML, Han AX, Gilmour R, Irwin M, Markey P, Freeman K, Higgins G, Turra M, Komadina N, Peck H, Booy R, Maurer-Stroh S, Dhanasekaran V, Sullivan S.

Euro Surveill. 2019 Aug;24(33). doi: 10.2807/1560-7917.ES.2019.24.33.1900421. Erratum in: Euro Surveill. 2019 Aug;24(34):.

3.

Emergence of Influenza A(H7N4) Virus, Cambodia.

Vijaykrishna D, Deng YM, Grau ML, Kay M, Suttie A, Horwood PF, Kalpravidh W, Claes F, Osbjer K, Dussart P, Barr IG, Karlsson EA.

Emerg Infect Dis. 2019 Oct;25(10):1988-1991. doi: 10.3201/eid2510.190506. Epub 2019 Oct 17.

4.

Circulation and characterization of seasonal influenza viruses in Cambodia, 2012-2015.

Horwood PF, Karlsson EA, Horm SV, Ly S, Heng S, Chin S, Darapheak C, Saunders D, Chanthap L, Rith S, Y P, Chea KL, Sar B, Parry A, Ieng V, Tsuyouka R, Deng YM, Hurt AC, Barr IG, Komadina N, Buchy P, Dussart P.

Influenza Other Respir Viruses. 2019 Sep;13(5):465-476. doi: 10.1111/irv.12647. Epub 2019 Jun 28.

5.

Respiratory Illness in a Piggery Associated with the First Identified Outbreak of Swine Influenza in Australia: Assessing the Risk to Human Health and Zoonotic Potential.

Smith DW, Barr IG, Loh R, Levy A, Tempone S, O'Dea M, Watson J, Wong FYK, Effler PV.

Trop Med Infect Dis. 2019 Jun 25;4(2). pii: E96. doi: 10.3390/tropicalmed4020096.

6.

Avian influenza in the Greater Mekong Subregion, 2003-2018.

Suttie A, Karlsson EA, Deng YM, Hurt AC, Greenhill AR, Barr IG, Dussart P, Horwood PF.

Infect Genet Evol. 2019 Oct;74:103920. doi: 10.1016/j.meegid.2019.103920. Epub 2019 Jun 13. Review.

PMID:
31201870
7.

Influenza A Virus Infection Induces Viral and Cellular Defective Ribosomal Products Encoded by Alternative Reading Frames.

Zanker DJ, Oveissi S, Tscharke DC, Duan M, Wan S, Zhang X, Xiao K, Mifsud NA, Gibbs J, Izzard L, Dlugolenski D, Faou P, Laurie KL, Vigneron N, Barr IG, Stambas J, Van den Eynde BJ, Bennink JR, Yewdell JW, Chen W.

J Immunol. 2019 Jun 15;202(12):3370-3380. doi: 10.4049/jimmunol.1900070. Epub 2019 May 15.

PMID:
31092636
8.

Rapid detection of new B/Victoria-lineage haemagglutinin variants of influenza B viruses by pyrosequencing.

Lau H, Deng YM, Xu X, Sessions W, Barr IG.

Diagn Microbiol Infect Dis. 2019 Apr;93(4):311-317. doi: 10.1016/j.diagmicrobio.2018.11.003. Epub 2018 Nov 13.

PMID:
30528425
9.

Cell culture-derived influenza vaccines in the severe 2017-2018 epidemic season: a step towards improved influenza vaccine effectiveness.

Barr IG, Donis RO, Katz JM, McCauley JW, Odagiri T, Trusheim H, Tsai TF, Wentworth DE.

NPJ Vaccines. 2018 Oct 9;3:44. doi: 10.1038/s41541-018-0079-z. eCollection 2018. Review.

10.

Influenza A(H5N1) viruses with A(H9N2) single gene (matrix or PB1) reassortment isolated from Cambodian live bird markets.

Suttie A, Karlsson EA, Deng YM, Horm SV, Yann S, Tok S, Sorn S, Holl D, Tum S, Hurt AC, Greenhill AR, Barr IG, Horwood PF, Dussart P.

Virology. 2018 Oct;523:22-26. doi: 10.1016/j.virol.2018.07.028. Epub 2018 Jul 31.

PMID:
30075357
11.

Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.

Korenkov DA, Laurie KL, Reading PC, Carolan LA, Chan KF, Isakova-Sivak II, Smolonogina TA, Subbarao K, Barr IG, Villanueva J, Shcherbik S, Bousse T, Rudenko LG.

Infect Genet Evol. 2018 Oct;64:95-104. doi: 10.1016/j.meegid.2018.06.019. Epub 2018 Jun 19.

12.

Divergent Human-Origin Influenza Viruses Detected in Australian Swine Populations.

Wong FYK, Donato C, Deng YM, Teng D, Komadina N, Baas C, Modak J, O'Dea M, Smith DW, Effler PV, Cooke J, Davies KR, Hurt A, Kung N, Levy A, Loh R, Shan S, Shinwari MW, Stevens V, Taylor J, Williams DT, Watson J, Eagles D, McCullough S, Barr IG, Dhanasekaran V.

J Virol. 2018 Jul 31;92(16). pii: e00316-18. doi: 10.1128/JVI.00316-18. Print 2018 Aug 15.

13.

Annual report of the National Influenza Surveillance Scheme, 2010.

Gavin K, Owen R, Barr IG.

Commun Dis Intell Q Rep. 2017 Dec 1;41(4):E348-E368.

14.

Incidence of influenza A(H3N2) virus infections in Hong Kong in a longitudinal sero-epidemiological study, 2009-2015.

Wei VWI, Wong JYT, Perera RAPM, Kwok KO, Fang VJ, Barr IG, Peiris JSM, Riley S, Cowling BJ.

PLoS One. 2018 May 24;13(5):e0197504. doi: 10.1371/journal.pone.0197504. eCollection 2018.

15.

Investigating Viral Interference Between Influenza A Virus and Human Respiratory Syncytial Virus in a Ferret Model of Infection.

Chan KF, Carolan LA, Korenkov D, Druce J, McCaw J, Reading PC, Barr IG, Laurie KL.

J Infect Dis. 2018 Jul 2;218(3):406-417. doi: 10.1093/infdis/jiy184.

PMID:
29746640
16.

Difficulties of predicting the timing, size and severity of influenza seasons.

Barr IG, Cheng AC.

Respirology. 2018 Jun;23(6):562-563. doi: 10.1111/resp.13310. Epub 2018 Apr 11. Review. No abstract available.

17.

The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia.

de Boer PT, Kelso JK, Halder N, Nguyen TP, Moyes J, Cohen C, Barr IG, Postma MJ, Milne GJ.

Vaccine. 2018 Feb 8;36(7):997-1007. doi: 10.1016/j.vaccine.2017.12.073. Epub 2018 Jan 17.

18.

Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages.

Laurie KL, Horman W, Carolan LA, Chan KF, Layton D, Bean A, Vijaykrishna D, Reading PC, McCaw JM, Barr IG.

J Infect Dis. 2018 Jan 30;217(4):548-559. doi: 10.1093/infdis/jix509.

19.

Pathogenesis, Humoral Immune Responses, and Transmission between Cohoused Animals in a Ferret Model of Human Respiratory Syncytial Virus Infection.

Chan KF, Carolan LA, Druce J, Chappell K, Watterson D, Young P, Korenkov D, Subbarao K, Barr IG, Laurie KL, Reading PC.

J Virol. 2018 Jan 30;92(4). pii: e01322-17. doi: 10.1128/JVI.01322-17. Print 2018 Feb 15.

20.

The first external quality assessment of isolation and identification of influenza viruses in cell culture in the Asia Pacific region, 2016.

Reading PC, Leung VK, Buettner I, Gillespie L, Deng YM, Shaw R, Spirason N, Todd A, Shah AS, Konings F, Barr IG.

J Clin Virol. 2017 Dec;97:54-58. doi: 10.1016/j.jcv.2017.10.018. Epub 2017 Nov 2.

PMID:
29127947
21.

Immune Responses to Twice-Annual Influenza Vaccination in Older Adults in Hong Kong.

Tam YH, Valkenburg SA, Perera RAPM, Wong JHF, Fang VJ, Ng TWY, Kwong ASK, Tsui WWS, Ip DKM, Poon LLM, Chau CKV, Barr IG, Peiris JSM, Cowling BJ.

Clin Infect Dis. 2018 Mar 5;66(6):904-912. doi: 10.1093/cid/cix900.

PMID:
29069368
22.

Epidemiology and Relative Severity of Influenza Subtypes in Singapore in the Post-Pandemic Period from 2009 to 2010.

Goh EH, Jiang L, Hsu JP, Tan LWL, Lim WY, Phoon MC, Leo YS, Barr IG, Chow VTK, Lee VJ, Lin C, Lin R, Sadarangani SP, Young B, Chen MI.

Clin Infect Dis. 2017 Nov 13;65(11):1905-1913. doi: 10.1093/cid/cix694.

23.

Multiplex Reverse Transcription-PCR for Simultaneous Surveillance of Influenza A and B Viruses.

Zhou B, Deng YM, Barnes JR, Sessions OM, Chou TW, Wilson M, Stark TJ, Volk M, Spirason N, Halpin RA, Kamaraj US, Ding T, Stockwell TB, Salvatore M, Ghedin E, Barr IG, Wentworth DE.

J Clin Microbiol. 2017 Dec;55(12):3492-3501. doi: 10.1128/JCM.00957-17. Epub 2017 Oct 4.

24.

Relative incidence and individual-level severity of seasonal influenza A H3N2 compared with 2009 pandemic H1N1.

Kwok KO, Riley S, Perera RAPM, Wei VWI, Wu P, Wei L, Chu DKW, Barr IG, Malik Peiris JS, Cowling BJ.

BMC Infect Dis. 2017 May 11;17(1):337. doi: 10.1186/s12879-017-2432-7.

25.

Assessing the potential pandemic risk of recent avian influenza viruses.

Barr IG.

Eur Respir J. 2017 Mar 8;49(3). pii: 1602517. doi: 10.1183/13993003.02517-2016. Print 2017 Mar. No abstract available.

26.

Evidence for the Introduction, Reassortment, and Persistence of Diverse Influenza A Viruses in Antarctica.

Hurt AC, Su YCF, Aban M, Peck H, Lau H, Baas C, Deng YM, Spirason N, Ellström P, Hernandez J, Olsen B, Barr IG, Vijaykrishna D, Gonzalez-Acuna D.

J Virol. 2016 Oct 14;90(21):9674-9682. doi: 10.1128/JVI.01404-16. Print 2016 Nov 1.

27.

Influenza C infections in Western Australia and Victoria from 2008 to 2014.

Jelley L, Levy A, Deng YM, Spirason N, Lang J, Buettner I, Druce J, Blyth C, Effler P, Smith D, Barr IG.

Influenza Other Respir Viruses. 2016 Nov;10(6):455-461. doi: 10.1111/irv.12402. Epub 2016 Jul 23.

28.

Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant.

Gordon DL, Sajkov D, Honda-Okubo Y, Wilks SH, Aban M, Barr IG, Petrovsky N.

Vaccine. 2016 Jul 19;34(33):3780-6. doi: 10.1016/j.vaccine.2016.05.071. Epub 2016 Jun 21.

29.

Differential age susceptibility to influenza B/Victoria lineage viruses in the 2015 Australian influenza season.

Barr IG, Vijaykrishna D, Sullivan SG.

Euro Surveill. 2016;21(4). doi: 10.2807/1560-7917.ES.2016.21.4.30118.

30.
31.

Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer.

Kotecha RS, Wadia UD, Jacoby P, Ryan AL, Blyth CC, Keil AD, Gottardo NG, Cole CH, Barr IG, Richmond PC.

Cancer Med. 2016 Feb;5(2):285-93. doi: 10.1002/cam4.596. Epub 2015 Dec 29.

32.

Trivalent and quadrivalent influenza vaccination effectiveness in Australia and South Africa: results from a modelling study.

Milne GJ, Halder N, Kelso JK, Barr IG, Moyes J, Kahn K, Twine R, Cohen C.

Influenza Other Respir Viruses. 2016 Jul;10(4):324-32. doi: 10.1111/irv.12367. Epub 2016 Feb 8.

33.

Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring.

Little K, Leang SK, Butler J, Baas C, Harrower B, Mosse J, Barr IG, Hurt AC.

Euro Surveill. 2015;20(45). doi: 10.2807/1560-7917.ES.2015.20.45.30060.

34.

Structural and functional characterisation of ferret interleukin-2.

Ren B, McKinstry WJ, Pham T, Newman J, Layton DS, Bean AG, Chen Z, Laurie KL, Borg K, Barr IG, Adams TE.

Dev Comp Immunol. 2016 Feb;55:32-8. doi: 10.1016/j.dci.2015.10.007. Epub 2015 Oct 22.

PMID:
26472619
35.

Innate Immunity and the Inter-exposure Interval Determine the Dynamics of Secondary Influenza Virus Infection and Explain Observed Viral Hierarchies.

Cao P, Yan AW, Heffernan JM, Petrie S, Moss RG, Carolan LA, Guarnaccia TA, Kelso A, Barr IG, McVernon J, Laurie KL, McCaw JM.

PLoS Comput Biol. 2015 Aug 18;11(8):e1004334. doi: 10.1371/journal.pcbi.1004334. eCollection 2015 Aug.

36.

Phylodynamics of H1N1/2009 influenza reveals the transition from host adaptation to immune-driven selection.

Su YCF, Bahl J, Joseph U, Butt KM, Peck HA, Koay ESC, Oon LLE, Barr IG, Vijaykrishna D, Smith GJD.

Nat Commun. 2015 Aug 6;6:7952. doi: 10.1038/ncomms8952.

37.

Quantifying relative within-host replication fitness in influenza virus competition experiments.

Petrie SM, Butler J, Barr IG, McVernon J, Hurt AC, McCaw JM.

J Theor Biol. 2015 Oct 7;382:259-71. doi: 10.1016/j.jtbi.2015.07.003. Epub 2015 Jul 15.

PMID:
26188087
38.

Inter-Seasonal Influenza is Characterized by Extended Virus Transmission and Persistence.

Patterson Ross Z, Komadina N, Deng YM, Spirason N, Kelly HA, Sullivan SG, Barr IG, Holmes EC.

PLoS Pathog. 2015 Jun 24;11(6):e1004991. doi: 10.1371/journal.ppat.1004991. eCollection 2015 Jun.

39.

A simplified Sanger sequencing method for full genome sequencing of multiple subtypes of human influenza A viruses.

Deng YM, Spirason N, Iannello P, Jelley L, Lau H, Barr IG.

J Clin Virol. 2015 Jul;68:43-8. doi: 10.1016/j.jcv.2015.04.019. Epub 2015 Apr 28.

40.

Global circulation patterns of seasonal influenza viruses vary with antigenic drift.

Bedford T, Riley S, Barr IG, Broor S, Chadha M, Cox NJ, Daniels RS, Gunasekaran CP, Hurt AC, Kelso A, Klimov A, Lewis NS, Li X, McCauley JW, Odagiri T, Potdar V, Rambaut A, Shu Y, Skepner E, Smith DJ, Suchard MA, Tashiro M, Wang D, Xu X, Lemey P, Russell CA.

Nature. 2015 Jul 9;523(7559):217-20. doi: 10.1038/nature14460. Epub 2015 Jun 8.

41.

Interval Between Infections and Viral Hierarchy Are Determinants of Viral Interference Following Influenza Virus Infection in a Ferret Model.

Laurie KL, Guarnaccia TA, Carolan LA, Yan AW, Aban M, Petrie S, Cao P, Heffernan JM, McVernon J, Mosse J, Kelso A, McCaw JM, Barr IG.

J Infect Dis. 2015 Dec 1;212(11):1701-10. doi: 10.1093/infdis/jiv260. Epub 2015 May 5.

42.

Oseltamivir reduces clinical illness in households in Bangladesh.

Barr IG, Kelly HA.

Lancet Infect Dis. 2015 Jun;15(6):617-9. doi: 10.1016/S1473-3099(15)70084-8. Epub 2015 Mar 16. No abstract available.

PMID:
25788163
43.

Influenza viruses with B/Yamagata- and B/Victoria-like neuraminidases are differentially affected by mutations that alter antiviral susceptibility.

Farrukee R, Leang SK, Butler J, Lee RT, Maurer-Stroh S, Tilmanis D, Sullivan S, Mosse J, Barr IG, Hurt AC.

J Antimicrob Chemother. 2015 Jul;70(7):2004-12. doi: 10.1093/jac/dkv065. Epub 2015 Mar 18.

PMID:
25786478
44.

A novel video tracking method to evaluate the effect of influenza infection and antiviral treatment on ferret activity.

Oh DY, Barr IG, Hurt AC.

PLoS One. 2015 Mar 4;10(3):e0118780. doi: 10.1371/journal.pone.0118780. eCollection 2015.

45.

The contrasting phylodynamics of human influenza B viruses.

Vijaykrishna D, Holmes EC, Joseph U, Fourment M, Su YC, Halpin R, Lee RT, Deng YM, Gunalan V, Lin X, Stockwell TB, Fedorova NB, Zhou B, Spirason N, Kühnert D, Bošková V, Stadler T, Costa AM, Dwyer DE, Huang QS, Jennings LC, Rawlinson W, Sullivan SG, Hurt AC, Maurer-Stroh S, Wentworth DE, Smith GJ, Barr IG.

Elife. 2015 Jan 16;4:e05055. doi: 10.7554/eLife.05055.

46.

Influenza gain-of-function experiments: their role in vaccine virus recommendation and pandemic preparedness.

Schultz-Cherry S, Webby RJ, Webster RG, Kelso A, Barr IG, McCauley JW, Daniels RS, Wang D, Shu Y, Nobusawa E, Itamura S, Tashiro M, Harada Y, Watanabe S, Odagiri T, Ye Z, Grohmann G, Harvey R, Engelhardt O, Smith D, Hamilton K, Claes F, Dauphin G.

MBio. 2014 Dec 12;5(6). pii: e02430-14. doi: 10.1128/mBio.02430-14.

47.

Molecular epidemiology of influenza A(H1N1)pdm09 virus among humans and swine, Sri Lanka.

Perera HK, Vijaykrishna D, Premarathna AG, Jayamaha CJ, Wickramasinghe G, Cheung CL, Yeung MF, Poon LL, Perera AK, Barr IG, Guan Y, Peiris M.

Emerg Infect Dis. 2014 Dec;20(12):2080-4. doi: 10.3201/eid2012.140842.

48.

Antibody landscapes after influenza virus infection or vaccination.

Fonville JM, Wilks SH, James SL, Fox A, Ventresca M, Aban M, Xue L, Jones TC, Le NMH, Pham QT, Tran ND, Wong Y, Mosterin A, Katzelnick LC, Labonte D, Le TT, van der Net G, Skepner E, Russell CA, Kaplan TD, Rimmelzwaan GF, Masurel N, de Jong JC, Palache A, Beyer WEP, Le QM, Nguyen TH, Wertheim HFL, Hurt AC, Osterhaus ADME, Barr IG, Fouchier RAM, Horby PW, Smith DJ.

Science. 2014 Nov 21;346(6212):996-1000. doi: 10.1126/science.1256427.

49.

Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection.

Fox A, Mai le Q, Thanh le T, Wolbers M, Le Khanh Hang N, Thai PQ, Thi Thu Yen N, Minh Hoa le N, Bryant JE, Duong TN, Thoang DD, Barr IG, Wertheim H, Farrar J, Hien NT, Horby P.

J Infect. 2015 Feb;70(2):187-96. doi: 10.1016/j.jinf.2014.09.003. Epub 2014 Sep 16.

50.

Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore.

Hsu JP, Zhao X, Chen MI, Cook AR, Lee V, Lim WY, Tan L, Barr IG, Jiang L, Tan CL, Phoon MC, Cui L, Lin R, Leo YS, Chow VT.

BMC Infect Dis. 2014 Jul 28;14:414. doi: 10.1186/1471-2334-14-414.

Supplemental Content

Support Center